ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
HyreCar Inc

HyreCar Inc (HYRE)

0.165
0.00
(0.00%)
Closed 21 December 8:00AM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.165
Bid
0.162
Offer
0.175
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.165
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

HYRE Latest News

HyreCar Cancels Special Meeting of Stockholders

LOS ANGELES, Feb. 28, 2023 (GLOBE NEWSWIRE) -- HyreCar Inc. (OTC: HYRE) (“HyreCar” or the “Company”) today announced cancellation of its virtual special meeting of stockholders that was...

HyreCar to Facilitate Sale of Business Through Voluntary Chapter 11 Process, Announces Leadership Changes

Continues to operate and meet owner and driver needs for a gig-focused digital carsharing marketplace Receives commitment for $5 million in debtor-in-possession financing LOS ANGELES, Feb. 27...

HyreCar Retains Northland Capital Markets as Advisor to Explore Strategic Alternatives

LOS ANGELES, Feb. 06, 2023 (GLOBE NEWSWIRE) -- HyreCar Inc. (OTC: HYRE) (“HyreCar” or the “Company”), the carsharing marketplace for ridesharing and food and package delivery services, today...

HyreCar Launches HyreCar Select Program to Increase Volume and Diversity of Car Supply

LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and food and package delivery services, today announced the launch of...

HyreCar Announces $12.25 Million in Financing to Further Accelerate Growth and Terminates “At-the-Market” Offering

LOS ANGELES, Jan. 06, 2023 (GLOBE NEWSWIRE) -- HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and food and package delivery services, today announced that it had raised...

HyreCar Focused on Sustainable Topline Growth and Profitability as In-fleeted and Net New Vehicle Counts Increase

LOS ANGELES, Dec. 12, 2022 (GLOBE NEWSWIRE) -- HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and food and package delivery services, today announced updates on progress...

HyreCar Announces Financial Results and Highlights for the Third Quarter 2022

LOS ANGELES, Nov. 14, 2022 (GLOBE NEWSWIRE) -- HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and food and package delivery services, today reported financial results...

HyreCar to Report Third Quarter 2022 Financial Results and Provide Corporate Update

LOS ANGELES, Nov. 07, 2022 (GLOBE NEWSWIRE) -- HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for ridesharing and food and package delivery services, today announced plans to release...

HyreCar, Inc. Announces Participation in LD Micro Main Event XV Conference

LOS ANGELES, Oct. 18, 2022 (GLOBE NEWSWIRE) -- HyreCar Inc. (NASDAQ: HYRE), the carsharing marketplace for rideshare and food/beverage delivery, today announced CEO Joe Furnari’s participation...

HyreCar's Fleet Partner AmeriDrive Initiates First New Car Purchases

Initial tranche of vehicles purchased with 1,500 more vehicles to be purchased over the next 6 monthsAmeriDrive expects to add 800 to 1,000 cars in current and new markets by the end of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

HYRE - Frequently Asked Questions (FAQ)

What is the current HyreCar share price?
The current share price of HyreCar is US$ 0.165
What is the 1 year trading range for HyreCar share price?
HyreCar has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
277.63M

Discussion

View Full Feed
StayHumble StayHumble 54 seconds ago
💹💹💹 https://theqcup.com/patents
HCMC
StayHumble StayHumble 4 minutes ago
💹$HCMC Heading 2Court💹StrongerCase Sufficient 2Disavow $PM💹! @InsidePMI Self Reports of

Less Combustion = No Combustion

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/6436df8d94fa09523deadf45/1681317773824/2023-04-12_HCMC_v_P
HCMC PM
capgain capgain 8 minutes ago
Do we know what was in the bill that passed last night?
StayHumble StayHumble 11 minutes ago
💹infinity incoming in SHORT Order💹Power2 the P1ayers💹💹💹
GME
CorsairNavigator20 CorsairNavigator20 16 minutes ago
What is your purpose on this board? This is a microcap not a large cap. If you are looking for dividends look at JEPQ an ETF that pays around 9% and it uses an .options strategy. Depends on your definition nice yield. Also I do take exception to the slobbering gambling addict since all stock mar
MRKR
hnbadger1 hnbadger1 20 minutes ago
The abstract of the patent application titled
"Therapy Selection and Treatment of Neurodegenerative Disorders" describes a method for individualized therapy selection and monitoring for neurodegenerative disorders. The focus is on using Sigma-1 receptor agonist therapy to treat neurodegenerat
AVXL
CanItBThisEZ2Make CanItBThisEZ2Make 22 minutes ago
BEST SELLERS RANK (BSR) IS 853 69 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
Frankestin Frankestin 25 minutes ago
the only weakness is the effect which is below average... I wrote previously... but they are average aspects in the sense that for some it is probably higher and for someone lower than average. The real question to which I cannot find an answer is: what cohen effect do the current remedies have?
TNXP
Wayne R Wayne R 29 minutes ago
Things got complicated since FINRA took charge.

Now companies can say, that is what we filed but that wasn't what we meant, after the fact.

Why they'd even bother with a 1 share roundup is a mystery, unless.., they don't like this company and want to make sure it gets d
VERB
capgain capgain 31 minutes ago
Please hurry!
edbi46 edbi46 34 minutes ago
Lets see how high our beloved BIEL gets TRUMPed/JFK JUNIORed/DR. OZed up by Jan. 1, before NOPAIN Act is activated ( and, specifically, after!!! ) !!!!!

No WORD SALADS, no SUBSTANTIAL/NONE SUBSTANTIAL ACCUSATIONS, ( for like 13 years, from Oct. 2011 and counting?? ), did/will do any d
MCF WBA
capgain capgain 36 minutes ago
Well, you have that right :)
marcis marcis 37 minutes ago
Bongu ☕️ Happy holidays 🎄

Saturday’s Cafe’ Chat.

$RDAR What market can this company capture or expand on?
It has $45 million, just announced this week, to start work with.

( maybe we should start a new chat board
Cafe
RDAR
glenn1919 glenn1919 40 minutes ago
LTRY.......................https://stockcharts.com/h-sc/ui?s=LTRY&p=W&b=5&g=0&id=p86431144783
LTRY
Wayne R Wayne R 43 minutes ago
Hey, come on by.

On the menu is lasagna with FIVE cheeses!!

I always make too much. It must be because of the genes passed down from my Hungarian grandmother.

She always had something cooking and ready to eat just in case someone came by and was hungry.
Mufaso Mufaso 43 minutes ago
No, VKTX doesn't have an agreement in place with anyone. Brian Lian has said that Viking will announce an agreement with someone by EOY although that could drag on a bit as Viking may have a bit more leverage now that CagriSema looks to be second rate.

I speculated that it is Bachem
VKTX
FanOfspringsteen FanOfspringsteen 51 minutes ago
Yesterday, though roughly 5 minutes before open market , the share price was shown down - 7.6% and -11% half an hour before. I don't know the reason why. 
IDCC
SkeBallLarry SkeBallLarry 52 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 53 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
SkeBallLarry SkeBallLarry 55 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
prototype_101 prototype_101 55 minutes ago
this new article by Lebby p6-7 leads me to believe that LWLG has suitors despite Lebby desire to stay as standalone

Electro-optic polymers – a revolution in optical switching?

https://online.flippingbook.com/view/660560119/6/
LWLG
SkeBallLarry SkeBallLarry 57 minutes ago
CountDown to Inauguration >

https://www.timeanddate.com/countdown/generic?iso=20250121T00&p0=413&msg=Countdown+to+Inauguration+%3E&font=cursive
shoondale shoondale 1 hour ago
Beside criminality, what qualifications does the bribery felon possess that Johnston and Williams would eagerly anoint him the president of their MedeSol company and then beg the judge to allow him to serve time as their president rather than serve his time to the society he swindled?
https:
MGON
hnbadger1 hnbadger1 1 hour ago
It seems like Anavex has built a proprietary software and diagnostic toolkit for CNS diseases using blarcamesine. They give a patient drug and measure before/after genetic response. They can then diagnose or determine risk for developing CNS diseases.
PERSONALIZED MEDICINE for most CNS diseas
AVXL